Fyn Kinases Play a Critical Role in Neuronal Apoptosis Induced by Oxygen and Glucose Deprivation or Amyloid-β Peptide Treatment

Overview

Journal CNS Neurosci Ther

Specialties Neurology
Pharmacology

Date 2012 Jun 20

PMID 22709448

Citations 25

Authors

Cai-Ping Du

Ran Tan

Xiao-Yu Hou

Affiliations

Soon will be listed here.

Abstract

Aims: Src family protein tyrosine kinases (SrcPTKs) have been implicated in the pathogenesis of brain ischemia and Alzheimer's disease (AD). In this study, we investigated whether Src and Fyn kinases, two major members of SrcPTKs in the brain, have distinct roles in the oxygen and glucose deprivation (OGD) and amyloid-β peptide (Aβ)-induced neuronal apoptosis.

Methods And Results: The DAPI staining and caspase-3 activation analysis showed that small interfering RNAs (siRNAs) knockdown of Src or Fyn attenuated SH-SY5Y cells apoptosis after OGD and Aβ treatment. Fyn knockdown had a more potent neuroprotective effect than Src knockdown, suggesting a principal pathological significance of Fyn in brain ischemia and AD. Previously, we reported that brain ischemia promotes the phosphorylation of postsynaptic density protein 95 (PSD-95) at tyrosine 523 (Y523), which is associated with postsynaptic mechanisms of excitotoxicity. Here, immunoblot analysis indicated that not only OGD but also Aβ incubation increased the PSD-95Y523 phosphorylation. Src knockdown, especially Fyn knockdown, significantly inhibited such phosphorylation.

Conclusion: Fyn mediates PSD-95Y523 phosphorylation, which may be responsible for the excitotoxic signal cascades and neuronal apoptosis in brain ischemia and Aβ neurotoxicity. Fyn is a potential therapeutic target for the treatment of ischemic stroke and AD.

Citing Articles

Neuronal Responses to Ischemia: Scoping Review of Insights from Human-Derived In Vitro Models.

Voogd E, Frega M, Hofmeijer J Cell Mol Neurobiol. 2023; 43(7):3137-3160.

PMID: 37380886 PMC: 10477161. DOI: 10.1007/s10571-023-01368-y.

3,5,3'-Triiodo-L-Thyronine Regulates Actin Cytoskeleton Dynamic in The Differentiated PC-12 Cells during Hypoxia through An αvβ3 Integrin.

Barbakadze T, Kvergelidze E, Bator J, Szeberenyi J, Mikeladze D Cell J. 2023; 25(4):247-254.

PMID: 37210645 PMC: 10201356. DOI: 10.22074/cellj.2022.557501.1059.

Fyn Signaling in Ischemia-Reperfusion Injury: Potential and Therapeutic Implications.

Du F, Tang T, Li Q, Liu J Mediators Inflamm. 2022; 2022:9112127.

PMID: 36157893 PMC: 9499810. DOI: 10.1155/2022/9112127.

Study on the Mechanism of Üstikuddus Sherbiti in Ischemic Cerebrovascular Diseases: Based on Network Pharmacology.

Gul A, Aimaiti M, Tuerxun T, Amat R, Reheman A, Zhang M Evid Based Complement Alternat Med. 2022; 2022:5581864.

PMID: 35432563 PMC: 9012636. DOI: 10.1155/2022/5581864.

Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury.

Huang P, Wan H, Shao C, Li C, Zhang L, He Y Front Pharmacol. 2022; 12:688596.

PMID: 35111041 PMC: 8801784. DOI: 10.3389/fphar.2021.688596.

References

Wu G, Hou X . Oligomerized Abeta25-35 induces increased tyrosine phosphorylation of NMDA receptor subunit 2A in rat hippocampal CA1 subfield. Brain Res. 2010; 1343:186-93. DOI: 10.1016/j.brainres.2010.04.055. View

Nair V, Niznik H, Mishra R . Interaction of NMDA and dopamine D2L receptors in human neuroblastoma SH-SY5Y cells. J Neurochem. 1996; 66(6):2390-3. DOI: 10.1046/j.1471-4159.1996.66062390.x. View

Haass C, Mandelkow E . Fyn-tau-amyloid: a toxic triad. Cell. 2010; 142(3):356-8. DOI: 10.1016/j.cell.2010.07.032. View

Sattler R, Tymianski M . Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol. 2002; 24(1-3):107-29. DOI: 10.1385/MN:24:1-3:107. View

Tezuka T, Umemori H, Akiyama T, Nakanishi S, Yamamoto T . PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci U S A. 1999; 96(2):435-40. PMC: 15154. DOI: 10.1073/pnas.96.2.435. View

Kornau H, Schenker L, Kennedy M, Seeburg P . Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science. 1995; 269(5231):1737-40. DOI: 10.1126/science.7569905. View

Salter M, Kalia L . Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci. 2004; 5(4):317-28. DOI: 10.1038/nrn1368. View

Trepanier C, Jackson M, Macdonald J . Regulation of NMDA receptors by the tyrosine kinase Fyn. FEBS J. 2011; 279(1):12-9. DOI: 10.1111/j.1742-4658.2011.08391.x. View

Du C, Gao J, Tai J, Liu Y, Qi J, Wang W . Increased tyrosine phosphorylation of PSD-95 by Src family kinases after brain ischaemia. Biochem J. 2008; 417(1):277-85. DOI: 10.1042/BJ20080004. View

10.

Wei W, Wang X, Kusiak J . Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J Biol Chem. 2002; 277(20):17649-56. DOI: 10.1074/jbc.M111704200. View

11.

Xu Y, Hou X, Liu Y, Zong Y . Different protection of K252a and N-acetyl-L-cysteine against amyloid-beta peptide-induced cortical neuron apoptosis involving inhibition of MLK3-MKK7-JNK3 signal cascades. J Neurosci Res. 2008; 87(4):918-27. DOI: 10.1002/jnr.21909. View

12.

Watson P, Humphries M, Relton J, Rothwell N, Verkhratsky A, Gibson R . Integrin-binding RGD peptides induce rapid intracellular calcium increases and MAPK signaling in cortical neurons. Mol Cell Neurosci. 2006; 34(2):147-54. DOI: 10.1016/j.mcn.2006.10.007. View

13.

Kohr G, Seeburg P . Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family. J Physiol. 1996; 492 ( Pt 2):445-52. PMC: 1158839. DOI: 10.1113/jphysiol.1996.sp021320. View

14.

Hynd M, Scott H, Dodd P . Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int. 2004; 45(5):583-95. DOI: 10.1016/j.neuint.2004.03.007. View

15.

Savinainen A, Garcia E, Dorow D, Marshall J, Liu Y . Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95. J Biol Chem. 2001; 276(14):11382-6. DOI: 10.1074/jbc.M100190200. View

16.

Tymianski M . Emerging mechanisms of disrupted cellular signaling in brain ischemia. Nat Neurosci. 2011; 14(11):1369-73. DOI: 10.1038/nn.2951. View

17.

Hou X, Liu Y, Zhang G . PP2, a potent inhibitor of Src family kinases, protects against hippocampal CA1 pyramidal cell death after transient global brain ischemia. Neurosci Lett. 2007; 420(3):235-9. DOI: 10.1016/j.neulet.2007.03.048. View

18.

Kalia L, Salter M . Interactions between Src family protein tyrosine kinases and PSD-95. Neuropharmacology. 2003; 45(6):720-8. DOI: 10.1016/s0028-3908(03)00313-7. View

19.

Pike C, Kosmoski J, Cribbs D, Glabe C, Cotman C . Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem. 1995; 64(1):253-65. DOI: 10.1046/j.1471-4159.1995.64010253.x. View

20.

Jantas D, Pytel M, Mozrzymas J, Leskiewicz M, Regulska M, Antkiewicz-Michaluk L . The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int. 2007; 52(4-5):864-77. DOI: 10.1016/j.neuint.2007.10.003. View